Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Impact of mild hypo- and hyperventilation on cerebral oxygen supply during general anesthesia.

Perioperative medicine (London, England)·2026
Same author

Correction: Postoperative cognitive dysfunction after beach chair positioning compared to supine position in orthopaedic surgery in the elderly.

Archives of orthopaedic and trauma surgery·2025
Same author

[Diagnosis and treatment of chronic coronary syndrome].

MMW Fortschritte der Medizin·2025
Same author

Prevalence and Prognostic Impact of Coronary Chronic Total Occlusions in Patients With Cardiogenic Shock.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025
Same author

Coronary Chronic Total Occlusions Affect Long-Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction.

Journal of the American Heart Association·2025
Same author

Impact of mild hypo- and hyperventilation on cerebral oxygen supply during general anesthesia.

Perioperative medicine (London, England)·2025

相关实验视频

Updated: May 6, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K

选择性抑制环氧化原酶-2增强了血小板粘附在仓鼠动脉体内体内的活体血小板.

Martin A Buerkle1, Selim Lehrer, Hae-Young Sohn

  • 1Institute of Physiology, Medizinische Poliklinik-Innenstadt, Ludwig-Maximilians University, Munich, Germany.

Circulation
|September 29, 2004
PubMed
概括

选择性循环氧化酶-2 (Cox-2) 抑制会增加血小板激活和血栓形成风险. 这项研究表明,Cox-2抑制降低了抗血小板性质,可能会在高危患者中引发血栓事件.

更多相关视频

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

12.8K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

相关实验视频

Last Updated: May 6, 2026

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.0K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

12.8K
Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

11.8K

科学领域:

  • 心血管科学 心血管科学
  • 药理学 药理学是指药理学的学科.
  • 微循环研究 微循环研究

背景情况:

  • 随着选择性环氧化酶-2 (Cox-2) 抑制剂的使用,报告了心血管方面的副作用.
  • 缺乏直接证据证明这些药物的前血栓性作用.
  • 这项研究调查了Cox-2抑制对活体血小板激活的影响.

研究的目的:

  • 调查选择性Cox-2抑制是否诱导微循环中的血小板激活.
  • 评估Cox-2抑制对血小板血管壁相互作用和微血管封闭的影响.
  • 为了确定对内皮释放的6 - 基托普罗斯塔格兰丁 (PG) F ((1alpha) 的影响.

主要方法:

  • 子内显微镜检测了光标记在子动脉中的人类血小板.
  • 对血小板血管壁相互作用 (PVWIs) 和稳固的血小板粘附的分析.
  • 在FeCl3引起的损伤和体外血小板粘附试验后评估微血管封闭.

主要成果:

  • 选择性Cox-2抑制 (NS-398) 在体内和体外显著增加了血小板粘附.
  • 增强了PVWI,并且损伤后血管封闭的时间显著缩短.
  • 考克斯-2抑制减少了6 - 基多-PGF的内皮释放.

结论:

  • 选择性Cox-2抑制减少了6-keto-PGF (α) 的释放,增加了血小板粘附和血栓形成风险.
  • 这些发现表明,Cox-2抑制剂可能通过降低内皮质的抗血小板性质来触发血栓事件.